| Name | Title | Contact Details |
|---|
Boomerang Capital is a Norwalk, CT-based company in the Financial Services sector.
Founded in 1991, Frazier Healthcare Partners is a leading provider of growth and venture capital to healthcare companies. With nearly $3.0 billion total capital raised, Frazier has invested in over 170 companies, with investment types ranging from company creation and venture capital to buyouts of profitable lower-middle market companies. The firm`s Growth Buyout team invests in healthcare and pharmaceutical services, medical products and related sectors. The Life Sciences team invests in therapeutics and related areas that are addressing unmet medical needs through innovation. Frazier has offices in Seattle, WA and Menlo Park, CA, and invests broadly across the US, Canada, and Europe.
NewBridge Global Ventures, Inc. is a growing U.S. company based in Orem, Utah engaged in management consulting as well as control and non-control acquisitions in the legal cannabis sector and its various verticals. The company`s three-pronged strategy, our "eco-system", allows for unique insight through consulting and the acquisition of start-up, mature or troubled companies that we believe can add significant value to the company`s other portfolio companies. NewBridge Global Ventures, Inc. is traded over the counter under the ticker symbol: NBGV. Our Mission: To improve the health and wellness of as many communities as possible. Our company will focus on global education of healthcare professionals and institutions, international producers, processors, and ditributors, as well as ancillary/supporting technologies that have an ability to impact the global healthcare and wellness industries.
Investment Funds Institute of Canada is a Mississauga, ON-based company in the Financial Services sector.
Emergence Capital is a top Silicon Valley venture capital firm focusing on enterprise cloud and software as a service (SaaS) applications. As a leading cloud VC, we assist early and growth stage startups seeking capital, particularly Series A and Series B financing. We enjoy investing in visionaries who are developing the next generation of enterprise technology.